Formycon AG (CHIX:FYBD) Moat Score: 0/10 (As of Jul. 11, 2026)


CHIX:FYBD Formycon AG CHIX:FYBD
56 GF Score
Price €63.30
GF Value €120.94
! 5 Warning Signs
View Full Analysis

What is Formycon AG Moat Score?

Formycon AG has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Formycon AG has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Formycon AG might have No Moat - No discernible moat.

Formycon AG  (CHIX:FYBd) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Formycon AG Moat Score Related Terms

CHIX:FYBD
56GF Score
Formycon AG CHIX:FYBD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Formycon AG (CHIX:FYBD) Overvalued in 2026?

Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued. The current stock price of €63.30 is trading 47.7% below its estimated GF Value™ of €120.94.

Key valuation signals for CHIX:FYBD:

  • Moat Score: 0
  • GF Value™: €120.94 vs. price of €63.30 (47.7% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the CHIX:FYBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Formycon AG Business Description

Address Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
56GF Score

Get the complete analysis for CHIX:FYBD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.30
Price
€120.94
GF Value